You have 9 free searches left this month | for more free features.

schizophrenia, neurodegeneration, s100b, gfap

Showing 1 - 25 of 3,402

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Schizophrenia Trial in Istanbul (GFAP, S100B)

Recruiting
  • Schizophrenia
  • GFAP, S100B
  • Istanbul, Turkey
    T.C. Sağlik Bilimleri Üniversitesi
Mar 28, 2022

Neuronal Damage in Patients Undergoing Robot-assisted

Recruiting
  • Brain Damage
  • +2 more
  • Mini Mental State Examination(MMSE),Montreal Cognitive Assessment ( MoCA),S100B ( protein S100 subunit beta) ,GFAP ( glial fibrillary acidic protein ),NSE ( neuron-specific enolase )
  • Antalya, Turkey
    Akdeniz University Hospital
Jan 12, 2023

Brain Injuries, Traumatic Brain Injury Trial (Single Group Assignment)

Not yet recruiting
  • Brain Injuries
  • Traumatic Brain Injury
  • Single Group Assignment
  • (no location specified)
Jan 26, 2022

Glial Fibrillary Acidic Protein and Ubiquitin Carboxy-terminal

Not yet recruiting
  • Traumatic Brain Injury
  • UCH-L1 GFAP
  • Angers, France
  • +14 more
May 30, 2023

Schizophrenia Trial in Worldwide (PP6M injection Dose 1, PP6M injection Dose 2)

Completed
  • Schizophrenia
  • PP6M injection Dose 1
  • PP6M injection Dose 2
  • Ciudad Autónoma De Buenos Aires, Argentina
  • +29 more
Jul 14, 2022

Schizophrenia Trial in Worldwide (Pimavanserin, Placebo)

Recruiting
  • Schizophrenia
  • Ciudad Autonoma Buenos Aires, Argentina
  • +82 more
Oct 14, 2021

Traumatic Brain Injury Trial in Montpellier (Blood samples)

Recruiting
  • Traumatic Brain Injury
  • Blood samples
  • Montpellier, France
    Montpellier University Hospital
Apr 30, 2021

Euthyroid Sick Syndrome Effect on Traumatic Brain Injury

Not yet recruiting
  • Euthyroid Sick Syndromes in Traumatic Brain Injury Patient and GFAP Level
    • (no location specified)
    Aug 23, 2022

    Mild Cognitive Impairment, Alzheimer Trial in Durham (lyophilized blueberry supplement)

    Recruiting
    • Mild Cognitive Impairment
    • Alzheimer Disease
    • lyophilized blueberry supplement
    • Durham, North Carolina
      Duke University Medical Center
    Feb 21, 2022

    Suicide, Depression Trial in Montpellier (Blood samples, Hetero-questionnaires and auto-questionnaires, Magnetic Resonance

    Not yet recruiting
    • Suicide
    • Depression
    • Blood samples
    • +2 more
    • Montpellier, France
      University hospital
    Sep 14, 2023

    Schizophrenia Trial in Athens (The combination of the Integrated Psychological Therapy and Metacognitive Training in individuals

    Recruiting
    • Schizophrenia
    • The combination of the Integrated Psychological Therapy and Metacognitive Training in individuals with schizophrenia and treatment resistant schizophrenia
    • Athens, Greece
      Stavroula Rakitzi
    Dec 15, 2022

    Hydrocephalus, Normal Pressure, Biochemical Lesions Head Region, Brain Damage Trial in Hradec Králové (Lumbar puncture, External

    Not yet recruiting
    • Hydrocephalus, Normal Pressure
    • +2 more
    • Lumbar puncture
    • +7 more
    • Hradec Králové, Czechia
      University Hospital Hradec Kralove
    Oct 13, 2023

    s100ß, NSE n GFAP in Living Donor Hepatectomy and Delirium

    Completed
    • Donor Site Complication
    • +3 more
    • Living Donor Hepatectomy
    • Antalya, Turkey
      Akdeniz University Medical Faculty Department of Anesthesiology
    Jan 7, 2022

    Retinal and Cognitive Dysfunction in Type 2 Diabetes

    Active, not recruiting
    • Retinal Function
    • +2 more
      • Barcelona, Spain
        Rafael Simó
      Aug 30, 2022

      Schizophrenia Trial in Worldwide (PP6M, PP3M 350 mg eq., PP3M 525 mg eq.)

      Completed
      • Schizophrenia
      • Rogers, Arkansas
      • +137 more
      Nov 11, 2021

      Neuropathy and Anti-GFAP Antibodies

      Active, not recruiting
      • Neurological Diseases or Conditions
      • Neurological Diseases Associated to Anti GFAP Antibodies
      • Clinical examination
      • electroneuromyography (ENMG)
      • Lyon, France
        Centre de référence des syndromes neurologiques paranéoplasiques
      Feb 14, 2023

      Negative Symptoms in Schizophrenia Trial (Metacognitive Training for Negative Symptoms (MCT), Supportive Counselling)

      Not yet recruiting
      • Negative Symptoms in Schizophrenia
      • Metacognitive Training for Negative Symptoms (MCT)
      • Supportive Counselling
      • (no location specified)
      Nov 6, 2023

      Schizophrenia, Oxidative Stress Trial in Fortaleza (Alpha-lipoic acid, Placebo Oral Tablet)

      Completed
      • Schizophrenia
      • Oxidative Stress
      • Alpha-lipoic acid
      • Placebo Oral Tablet
      • Fortaleza, CE, Brazil
        Núcleo de Pesquisa e Desenvolvimento de Medicamentos - UFC
      Aug 26, 2022

      Schizophrenia and Related Disorders Trial in United States (Aerobic Exercise, Stretching and Toning Exercise)

      Active, not recruiting
      • Schizophrenia and Related Disorders
      • Aerobic Exercise
      • Stretching and Toning Exercise
      • Stanford, California
      • +3 more
      Oct 3, 2022

      Schizophrenia Trial in Worldwide (SEP-363856 75mg, SEP-363856 100mg, Placebo)

      Recruiting
      • Schizophrenia
      • SEP-363856 75mg
      • +2 more
      • Little Rock, Arkansas
      • +63 more
      Dec 12, 2022

      Prognostic Potential of Prehospital Biomarkers in TBI Patients

      Completed
      • Traumatic Brain INjury
      • Blood sampling
      • Aarhus N, Denmark
        Prehospital Emergency Medical Services, Central Denmark Region
      Apr 23, 2019

      Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1

      Recruiting
      • Schizophrenia
      • +2 more
      • 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
      • New Haven, Connecticut
        Connecticut Mental Health Center
      Sep 16, 2022

      Obesity, Ketogenic Dieting, Metabolic Syndrome Trial in Stanford (LCHF, Ketogenic Diet)

      Completed
      • Obesity
      • +7 more
      • LCHF, Ketogenic Diet
      • Stanford, California
        Stanford University Department of Psychiatry & Behavioral Scienc
      Dec 6, 2022

      Schizophrenia, Schizophrenia-related Psychotic Disorder Trial in Poland, Romania, United Kingdom (Placebo, GWP42003)

      Completed
      • Schizophrenia
      • Schizophrenia-related Psychotic Disorder
      • Czeladź, Poland
      • +14 more
      Sep 22, 2022

      Depression Trial in Montpellier (Biological analysis)

      Recruiting
      • Depression
      • Biological analysis
      • Montpellier, France
        University hospital
      Oct 22, 2021